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Abstract. Neural stem/progenitor cells (NSPCs) give rise to billions of cells during development and are critical for proper
brain formation. The finding that NSPCs persist throughout adulthood has challenged the view that the brain has poor
regenerative abilities and raised hope for stem cell-based regenerative therapies. For decades there has been a strong movement
towards understanding the requirements of NSPCs and their regulation, resulting in the discovery of many transcription factors
and signaling pathways that can influence NSPC behavior and neurogenesis. However, the role of metabolism for NSPC
regulation has only gained attention recently. Lipid metabolism in particular has been shown to influence proliferation and
neurogenesis, offering exciting new possible mechanisms of NSPC regulation, as lipids are not only the building blocks of
membranes, but can also act as alternative energy sources and signaling entities. Here I review the recent literature examining
the role of lipid metabolism for NSPC regulation and neurogenesis.
Keywords: Neurogenesis, neural stem cells, lipid metabolism, lipogenesis, fatty acid oxidation, essential fatty acids, dietary
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INTRODUCTION
An adult human brain weighs around one and a half
kilograms and contains hundreds of billions of neu-
rons and glia, generated by neural stem/progenitor
cells (NSPCs) during embryonic and postnatal devel-
opment [1, 2]. Disruption of neurogenesis and
gliogenesis leads to massive brain dysfunction or
death [3, 4]. The findings that NSPCs not only per-
sist throughout adulthood, but that adult neurogenesis
plays an important role in learning and memory pro-
cesses and disease [1, 2, 5, 6], further emphasize
how delicately NSPC behavior is regulated. Given
the vital importance of brain function, a large amount
of research has been dedicated to understanding
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brain development and NSPC regulation and the
many transcription factors and signaling pathways
involved in this process [3, 4, 7]. Although most of
the signaling cascades eventually influence cellular
metabolism to a certain extent, the role of metabolism
as an active regulator of stem cell behavior has
only recently gained attention. Technical advances
to analyze metabolic profiles (reviewed by [8]) have
enabled in-depth profiling of various stem cells, and
there are now several publications that have identified
significant metabolic differences between stem cells
and their progeny that point towards a regulatory role
of cellular metabolism for stem cell activity. Recently
this has been shown to be similar in NSPCs as well
[9–12].
The emerging particular role for lipid metabolism
to govern proliferation and neurogenesis is the focus
of this review. A simple definition of the term
“lipids” is challenging as it comprises a large amount
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of biological substances with different properties,
with the most frequently used definition referring
to poor solubility in water and good solubility
in organic solvents (for a comprehensive resource
refer to the “LIPID MAPS Lipidomics Gateway”,
http://www.lipidmaps.org). Recent efforts to facili-
tate communication about lipid research has led to
eight lipid categories comprising fatty acyls, glyc-
erolipids, glycerophospholipids, sphingolipids, sterol
lipids, prenol lipids, saccharolipids, and polyketides
[13, 14]. Within these groups, a large amount of
lipids exists with distinct variability, making the study
of lipid metabolism a challenging field. Their piv-
otal role as a structural component in every plasma
membrane/organelle membrane as well as their high
energy content make these molecules indispensable
for higher organisms. Furthermore, their ability to act
as signaling molecules has only begun to be appre-
ciated and provides a source of as yet undiscovered
signaling mechanisms [15].
In this review I will discuss the recent literature
examining the role of lipid metabolism for NSPC
regulation and neurogenesis, with a special focus on
adult neurogenesis. To facilitate understanding, an
overview of the major lipid metabolic pathways dis-
cussed here is shown in a simplified scheme (Fig. 1).
FATTY ACID-BINDING PROTEINS
IN NSPCS
Most cells obtain their lipids either by synthesiz-
ing them de novo via lipogenesis or by taking them up
from circulation. As lipids are poorly soluble in aque-
ous solutions, they need to be transported in a bound
form, which in the blood stream usually occurs via
albumin, and intracellularly via a class of transport
proteins called fatty acid-binding proteins (FABPs)
[16]. Three out of ten members of the FABPS, namely
FABP3, FABP5 and FABP7 (also called brain lipid
binding protein, BLBP) show expression in the devel-
oping and adult brain [17, 18]. The expression pattern
of these FABPs correlates with specific processes:
FABP3 correlates with neurite formation, synapse
maturation and myelinogenesis, and FABP5 (and
FABP7) are expressed during neuronal cell differ-
entiation and migration. Of special interest in the
context of NSPCs is the peak of FABP7 expression,
which occurs in mouse around embryonic day 14, the
time when neuroepithelial cells transition into radial
glial cells [18]. Due to its enrichment in radial glial
cells during development but also in the adult brain,
FABP7 is now widely used as a NSPC marker protein
[19–21]. It has been shown that FABP7 is a direct
target of Notch and Pax6 signaling, two signaling
pathways highly relevant for NSPCs [22, 23]. The
first functional proof for its importance in neuroge-
nesis came from a lineage analysis using a FABP7
(BLBP) promoter-driven Cre recombinase mouse in
combination with a Rosa26 reporter mouse, show-
ing that FABP7 is indeed expressed in all radial glial
cells throughout the brain and that almost all neurons
are derived from these FABP7 expressing cells [24].
Surprisingly, despite complete knockout of FABP7,
mice were viable and macroscopic brain structure was
normal [25], probably due to compensatory mecha-
nisms even though expression of the other FABPs
was unaltered. However, a more detailed analysis by
the same group showed a clear decrease in the num-
ber of GFAP positive cells in the dentate gyrus (DG)
(including radial glia-like cells and astrocytes) and
a reduction in proliferation in 4 week-old FABP7
null mice [26, 27], suggesting its functional impor-
tance for neurogenesis. Altered emotional behavioral
responses and schizophrenic features also have been
shown in FABP7 null mice [25, 26]. However, those
effects might not only be due to altered neuroge-
nesis: a recent study with FABP7 knockout mice
shows that the lack of this protein in all astro-
cytes throughout the brain led to aberrant dendritic
morphology and decreased spine density in neu-
rons, accompanied with altered behavior. Behavioral
deficits can be partially rescued by transplantation
of wildtype astrocytes, suggesting a wider role of
this protein for brain function [28]. To properly
distinguish between a general astrocyte influence
and altered neurogenesis, conditional knockout mice
for FABPs need to be generated allowing for bet-
ter tissue-specific and temporal control of gene
deletion.
DE NOVO LIPOGENESIS IS IMPORTANT
FOR NSPC BEHAVIOR
The high expression of FABPs in NSPCs might
suggest that they rely entirely on fatty acid uptake
from the environment. However, we have recently
shown that the alternative way to obtain lipids,
namely de novo lipogenesis, is indeed crucial for
proliferating NSPCs [29]. In this complex pro-
cess orchestrated by the multidomain enzyme fatty
acid synthase (FASN), 2 carbons coming from
malonyl-CoA are sequentially added to an activated
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Fig. 1. A simplified scheme of the major lipid metabolic pathways in NSPCs. Shown is a schematic drawing of the major lipid metabolic
pathways discussed in this review. The numbers indicate the pathways listed in the left hand corner and correspond to the order of appearance
in this review. In brief: NSPCs derive their lipids either by taking up nutritional lipids/essential fatty acids (box number 5) through fatty
acid binding proteins (box number 1) or synthesize the lipids de novo (box number 2). Lipids, especially cholesterol (box number 3) and
complex fatty acids/polyunsaturated fatty acids (box number 2) form important building blocks of all membranes. In addition, lipids can
serve as energy substrates and are broken down by fatty acid oxidation in the mitochondria (box number 4) and peroxisomes (not shown).
Furthermore, lipids have important signaling functions (box number 6). For more details, please refer to the main text. Abbreviations: TCA
(tricarboxylic acid) cycle, CoA (Coenzyme A), FASN (fatty acid synthase), HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A).
acetyl-CoA to form a growing fatty acid chain (for a
review of de novo lipogenesis, see [30]). The major
product of FASN, palmitic acid, serves as a build-
ing block and can be elongated and unsaturated to
form more complex lipids. Similar to cancer cells,
which produce the majority of their lipids de novo
[31], NSPCs also up-regulate the lipogenic path-
way during proliferation [29]. The observed high
activity level of FASN in proliferating NSPCs is func-
tionally important, as pharmacological and genetic
inhibition led to significant decreases in prolifera-
tion. Furthermore, inducible conditional knockout of
Fasn in adult mice in Nestin-expressing NSPCs led
to a drastic reduction in neurogenesis, both in the
subventricular zone (SVZ) and in the DG, showing
the important role of lipid metabolism for adult
neurogenesis [29]. Upregulation of de novo lipoge-
nesis was hindered in quiescent NSPCs through the
action of Spot14, a small protein previously impli-
cated in lipid metabolism, which is highly enriched
in quiescent NSPCs that can give rise to neurons and
astrocytes in vivo [29]. High expression of Spot14 in
quiescent NSPCs was recently confirmed in an unbi-
ased single cell RNA-sequencing approach, where
Spot14 was among the top 35 genes enriched in
quiescent NSPCs [32]. Spot14 acts as a regulator
of FASN by reducing Malonyl-CoA levels, which
serves as a substrate for FASN, thus lowering sub-
strate availability for de novo lipogenesis [29, 33].
Knocking down Spot14 resulted in increased NSPC
activation, further confirming its regulatory role for
NSPC behavior. In vivo studies showed that Spot14
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positive NSPCs respond dynamically to neurogenic
regulators, with increased proliferation to positive
stimuli such as running, and decreased amounts of
Spot14 positive NSPCs with aging [34]. Furthermore,
ablation of the proliferating pool with a cytostatic
drug triggered the quiescent Spot14 positive NSPCs
to proliferate, showing that the brake on de novo
lipogenesis can be released if needed [34]. Inter-
estingly, shortly after the initial description of the
role of de novo lipogenesis in adult NSPCs [29],
another study was published addressing the role of
FASN for exercise-mediated cognitive enhancement
[35]. Increased FASN mRNA levels accompanied
increased proliferation of NSPCs in the hippocam-
pus of adult mice upon running. Subsequent fatty acid
profiling further revealed higher palmitic acid levels,
the major product of FASN activity. Moreover, when
FASN was inhibited by chronic intracerebroven-
tricular infusion of an inhibitor, exercise-induced
increase in proliferation was prevented and the
beneficial effects of exercise on cognition were
disrupted [35].
Recently, it has been suggested that the abun-
dance of lipids in niche cells surrounding NSPCs
also can directly influence NSPC behavior. Lipids
can be stored in so-called lipid droplets, and in
Drosophila these lipid droplets were shown to have
beneficial effects during oxidative stress [36]. The
authors showed that the lipid droplets provided a
“safe” storage for membrane polyunsaturated fatty
acids (PUFAs) when reactive oxygen species (ROS)
levels were high and that protection from lipid per-
oxidation was necessary for neuroblasts (the NSPCs
in Drosophila) to proliferate [36]. How exactly this
mechanism is initiated and whether similar mecha-
nisms exist in mammalian neurogenic niches remains
to be elucidated. In the mammalian brain, ependy-
mal cells which form part of the neurogenic niche,
have been long known for their accumulation of lipid
droplets [37] however, the function of those lipid
droplets so far has not been studied in detail. A
recent report associated an increase in lipid droplets
in the ependymal cells with Alzheimer’s disease
[38]. In a triple-transgenic mouse model, ependymal
cells had a massive increase in lipid droplets, which
was accompanied by reduced NSPC proliferation.
Such a reduced proliferation was also achieved when
lipids were locally increased by intracerebroventricu-
lar infusion of oleic acid in wildtype mice, suggesting
a direct link between lipid accumulation in niche cells
and NSPC regulation [38]. Taken together, FASN
dependent de novo lipogenesis in NSPCs and lipid
accumulation in niche cells seem to directly regulate
NSPC behavior.
CHOLESTEROL METABOLISM
IS CRITICAL FOR PROPER
NEUROGENESIS
Similar to other lipids, cholesterol is either pro-
duced de novo or taken up from the circulation,
although in the brain, de novo synthesis is the pre-
ferred pathway, especially during development [39].
Cholesterol is a major component of membranes and
especially enriched in the brain, as it is a key compo-
nent of the myelin sheets that isolate the axons [39].
Cholesterol is also crucial for synaptogenesis and
manipulation of cholesterol synthesis led to massive
brain developmental defects [40]. Despite these mas-
sive effects on brain development, only a few studies
have addressed the role of cholesterol in NSPCs.
An elegant study used conditional ablation of squa-
lene synthase, one of the key enzymes in cholesterol
biosynthesis, specifically in NSPCs [41]. This genetic
manipulation resulted in reduced brain size caused by
massive apoptosis of newborn neurons. The NSPCs
however, which were the target of cholesterol synthe-
sis ablation, were largely unaffected. Instead, NSPCs
showed an increase in lipid droplets presumably
reflecting increased uptake of cholesterol-bearing
lipoproteins from external sources. Supporting this
hypothesis, NSPCs in mutant embryos upregulated
vascular endothelial growth factor (VEGF), which
triggers angiogenesis, thereby potentially increas-
ing their supply of cholesterol-rich lipoproteins [41].
Although disturbances in cholesterol metabolism
seem to affects newborn neurons to a greater extent
than NSPCs, another recent study showed that
reduced activity of one of the enzymes in the
cholesterol synthesis pathway also disrupts the radial
glial fiber scaffold which is provided by NSPCs
for the migration of newborn neurons [42]. Fur-
thermore, such reduction in cholesterol biosynthesis
affected cell division behavior and led to prema-
ture differentiation and loss of self-renewal [42].
Thus, the massive brain developmental defects seen
with cholesterol metabolism mutations are likely
a result of defects in both NSPCs and newborn
neurons. Interestingly, cholesterol supplementation
in pregnant mice ameliorated the phenotype in the
cholesterol biosynthesis-compromised embryos [42],
suggesting that nutritional lipids might significantly
influence NSPCs and neurogenesis (see “The role
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of nutritional lipids on NSPCs and neurogenesis”
below).
THE ROLE OF FATTY ACID OXIDATION
FOR NSPC REGULATION
Not only the buildup, but also the breakdown of
lipids has recently gained attention in the field of
stem cell research. The breakdown of lipids occurs
via fatty acid oxidation (FAO), mainly in the mito-
chondria and to a lesser part in the peroxisomes (for
very-long-chain fatty acids). This pathway is tightly
regulated, as fatty acids cannot enter mitochondria
by diffusion but have to be actively transported via
a carnitine shuttle system [43]. Oxidation occurs as
fatty acids are broken down into acetyl-CoA, which
can enter the tricarboxylic acid cycle (TCA) for fur-
ther energy production, or be used elsewhere, for
instance for protein and histone acetylation or as
an alternative carbon source [44, 45]. During each
oxidation reaction, reduced nicotinamide adenine
dinucleotide (NADH), reduced flavin adenine din-
ucleotide (FADH) and acetyl-CoA is produced, all
of which can be used for ATP production. Thus,
the energy yield per molecule palmitic acid is more
than three times higher than per glucose molecule,
making lipids highly efficient energy storing
molecules.
A recent study showed that hematopoietic stem
cells (HSCs) rely on FAO for stem cell maintenance
and that inhibition of FAO led to an exhaustion of
the stem cell pool [46], suggesting an important role
of lipid breakdown in HSC biology. However, most
classical textbooks state that the brain cannot use
fatty acids as an energy source and relies solely on
glucose/lactate and ketone bodies. This almost dog-
matic view neglects many reports in the early 1970s
showing that astrocytes are indeed capable of utiliz-
ing fatty acids for energy production and that this also
occurs to a certain amount in vivo [47–51]. For a long
time it was thought that fatty acids are not penetrating
the blood brain barrier, but this has been disproven
experimentally [52, 53]. There are other arguments
reviewed elsewhere [54], explaining the preferred use
of glucose over fatty acids in the brain, but the fact
that astrocytes have the necessary machinery to do
so raises the question of whether NSPCs might use
this metabolic pathway as well. Indeed, a recent study
reported that adult NSPCs in the SVZ rely on FAO
and that inhibition of FAO decreased proliferation
[55]. New data confirm an important role for FAO
in NSPCs, suggesting that this pathway is specifi-
cally up-regulated in quiescent NSPCs (Knobloch et
al. unpublished), and suggest that the two opposite
pathways, breakdown and build-up of fatty acids,
are important for different stages of NSPC devel-
opment. Supporting our findings (Knobloch et al.
unpublished), many proteins involved in the FAO
pathway were enriched in the quiescent NSPC popu-
lation in single cell RNA sequencing data [32].
Recently, a link has been reported between the
clinical association of inborn FAO deficiencies with
developmental neuropsychiatric diseases [56]. Inhi-
bition of FAO in the embryonic cortex resulted in a
reduction of NSPCs and an increased differentiation,
suggesting that FAO might act similarly as in HSCs
to maintain the NSPC pool [56]. How exactly FAO
exerts this effect remains to be established.
THE ROLE OF NUTRITIONAL LIPIDS
ON NSPCS AND NEUROGENESIS
As NSPCs can take up circulating lipids, the avail-
ability of nutritional lipids might have an impact on
NSPC behavior. The high fat diet in the Western world
causes increasing health problems, with the result-
ing obesity linked to heart failures, stroke, diabetes
and cancer [57]. A few groups have addressed the
overall effects of circulating lipids on NSPCs and
neurogenesis. In adult rats, four weeks of high fat diet
led to reduced neurogenesis in males without signs
of obesity, whereas female rats did gain weight but
did not show altered neurogenesis [58]. This some-
how surprising gender difference was suggested to be
due to altered serum corticosterone levels upon high
fat diet only occurring in males [58]. Interestingly,
another study showed that high fat diet negatively
affected NSPC proliferation and neurogenesis in a
mouse strain-specific manner, with the strain more
susceptible to obesity being much more affected [59],
suggesting that altered physiological factors might
cause the decrease in neurogenesis. Another study
however, showed that high fat diet only negatively
affected neurogenesis during a critical “adolescence”
period and had no effect if ingested during adulthood
[60]. Likewise, maternal obesity induced by high
fat diet before and during pregnancy also negatively
affected neurogenesis in the offspring [61]. Although
in all these studies there seems to be a general negative
effect of high fat diet on neurogenesis, the criti-
cal exposure time and the mechanisms of action are
not clear.
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A different picture regarding the effect of cir-
culating lipids on neurogenesis emerges in the
hypothalamus. This particular brain structure senses
the availability of peripheral nutrients, such as glu-
cose and circulating lipids and regulates fasting and
feeding behavior [62]. It has recently been shown
that the hypothalamus also has ongoing neurogenesis
throughout adulthood, with the NSPCs being so-
called tanycytes that have radial glia-like phenotypes
and are located around the third ventricle (reviewed
by [63]). The formation of new neurons in the
adult hypothalamus has been associated with energy
balance [64, 65], and a recent publication demon-
strated that these newborn neurons were responsive
to metabolic stimuli and increased proliferation upon
high-fat diet [66]. Furthermore, upon ablation of
hypothalamic neurogenesis by focal irradiation, mice
fed a high fed diet gained less weight, probably
due to an increased energy expenditure and activity,
suggesting that the newborn neurons in the hypotha-
lamus actively contribute to regulation of feeding
and activity behavior [66]. Interestingly, other studies
published at the same time showed reduced neuroge-
nesis upon high fat diet, however looking at another
hypothalamic region [67, 68]. These opposing effects
of circulating lipids on two neurogenic areas in the
hypothalamus were confirmed in a further study [69].
Taken together, these data suggest that there is indeed
a direct effect of circulating lipids on adult NSPCs,
but at the same time also reveal that such effects are
context- or niche-dependent and need to be studied
in much more detail.
THE SPECIAL ROLE OF ESSENTIAL
FATTY ACIDS FOR NEUROGENESIS
Mammalians can synthesize most of the different
types of lipids de novo with the exceptions of two n-
3 and n-6 polyunsaturated fatty acids (PUFAs), also
known as omega-3 and omega-6 fatty acids that are
essential fatty acids and must be obtained via nutri-
tion. Although in strict terms, there are only two
essential fatty acids, alpha-linolenic acid (ALA, an
omega-3 fatty acid) and linoleic acid (LA, an omega-
6 fatty acid), some of the fatty acids derived from
these two precursors, such as for instance, docosa-
hexaenoic acid (DHA) and arachidonic acid (AA),
are also often considered as conditionally essential
due to their low conversion rate from their precur-
sors [70]. As both DHA and AA have been shown
to be required for proper brain development and
decrease with age [71–73], the majority of studies
on the role of nutritional lipids on NSPCs and neu-
rogenesis have focused on DHA and AA. DHA is
produced by microalgae and accumulates in all ani-
mals that feed on them, thus is especially enriched in
fish. Interestingly, the inclusion of aquatic food into
the human diet has been put forward as a driver for
human brain evolution, linking DHA to the increase
in brain size [74–76]. Besides being very rich in lipids
in general, the brain is the organ with the highest
amount of DHA [77]. DHA is mainly incorporated
into membrane lipids and has been shown to criti-
cally influence membrane properties such as fluidity,
required for optimal function [78]. Furthermore, it
has been shown to be involved in various signaling
cascades and inflammatory processes, not only in the
brain, but also throughout the body [74, 75]. AA is
mainly found in meat and eggs, and is sufficiently
available in a Western diet. AA also serves as a precur-
sor for eicosanoids, which in turn are major regulators
of the immune system and inflammatory processes
[79]. Thus, the complex mechanisms of action of
both DHA and AA might exert direct and indirect
influence on the brain. Here, only studies directly
addressing the role of DHA and AA on NSPCs and
neurogenesis are reviewed.
The classical approach to increase the incorpora-
tion of DHA and AA into membranes in cells and
in the brain is by supplementing DHA/AA in the
medium or providing a diet rich in their precur-
sors. Several laboratories chose this approach and
the general picture that emerges from these stud-
ies is that these two PUFAs are indeed beneficial
for neurogenesis both during development and in
the adult, promoting neuronal differentiation. The
detailed effects however differ between studies, likely
due to experimental designs. NSPCs readily incor-
porated DHA and/or AA that was supplemented in
the medium and their membrane lipid profile was
more similar to the in vivo situation upon supple-
mentation [80], again pointing towards a need for
modifying current culture protocols. Increased avail-
ability of PUFAs also increased NSPC proliferation
and altered protein localization in lipid rafts [80],
however, the consequences of such altered localiza-
tion was not addressed further. When pregnant female
rodents were fed a diet deficient with omega-3 fatty
acids, the developing embryos had a smaller cortical
plate, hippocampus, and dentate gyrus [81]. NSPCs
derived from pups that developed with a maternal
diet deficient in omega-3 fatty acid further showed
marked and long-lasting effects both on proliferation
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and differentiation, which were visible up to 40 days
in vitro [82]. The number of surviving newborn neu-
rons in vivo was significantly higher with DHA and
this was attributed to increased neuronal differenti-
ation and maturation of NSPCs with a reduction in
proliferation and cell death, as seen in vitro [83, 84].
In old rats, only 12 weeks of DHA (and eicosapen-
taenoic acid (EPA)) supplementation was sufficient to
reverse age-related decreases in fatty acid receptors
and alleviated the decrease in the number of imma-
ture neurons, as is usually seen in old animals [85].
Similarly, supplementation of DHA in combination
with voluntary exercise, a well known pro-neurogenic
stimulus per se, further enhanced synaptic plasticity
and cognition, suggesting that pro-neurogenic stimuli
might have more room to act when PUFA availability
is increased [86]. An elegant approach to artificially
increase endogenous DHA in mice was achieved by
expression of the C. elegans fat-1 gene that allows
conversion of the more abundant omega-6 fatty acids
into omega-3 fatty acids [87]. Fat-1 transgenic mice
had increased proliferation of NSPCs in vivo [88]
and also showed improved cognitive performance.
However, this is most probably due to the increase in
dendritic spines in CA1 neurons in Fat-1 mice [88],
supporting the important role of DHA for neuronal
function and health.
Supplementation of the diet specifically with AA
was shown to increase NSPC proliferation [89] and
an in vitro study suggested that while DHA promotes
neuronal differentiation, AA might exert its effects
more via maintenance of the NSPC pool [90]. Sup-
port for this hypothesis also comes from an AA and
DHA supplementation study in aged mice. While AA
alone increased proliferation of NSPCs in aged mice,
DHA correlated with the number of surviving new-
born neurons [91]. Surprisingly, a combination of
the two PUFAs did not outperform the single enrich-
ment, which might be explained by the requirement
of an “optimal” rate of omega-6 to omega-3 PUFAs,
as shown by a recent study addressing the role of
too high AA versus DHA ratio [92]. Taken together,
the important role of essential fatty acids for proper
brain development demonstrates well the key role
lipids play for neurogenesis. The evidence that there
is requirement for a certain ratio of AA and DHA fur-
ther illustrates the complexity of this research topic.
An isolated view on the role of a certain lipid class
might lead to the wrong conclusions and not reflect
the complex interplay and competitive behavior of
different lipid species. Thus, special care has to be
taken when addressing the nutritional influence of
lipids on neurogenesis not to oversimplify experi-
mental setups.
THE ROLE OF LIPIDS AS SIGNALING
ENTITIES IN NSPCS
As mentioned in the introduction, lipids do not
only serve as membrane building blocks or energy
molecules but also have a wide variety of signaling
functions. They can either directly serve as ligands for
membrane and nuclear receptors, such as for instance,
for the peroxisome proliferator-activated receptors
(PPARs) which in turn act as transcription factors
[93]. Lipids can also influence signaling via mem-
brane microdomains called lipid rafts, which form
protected areas and can cluster corresponding recep-
tors and ligands. Lipid rafts are highly relevant for
signaling cascades involved in stem cell maintenance
such as wnt/beta-catenin, EGF- and insulin signal-
ing [94, 95]. Last but not least, lipids can serve as
lipid tags on proteins, which alters protein localiza-
tion and by this influences signaling cascades, as is
the case for instance, for sonic hedgehog signaling
[96]. Interestingly, a disturbance in membrane lipids
and their signaling function has also been implicated
in the development of major depression (reviewed by
[97]). As defective neurogenesis has been linked to
the disease pattern of depression [5], understanding in
more detail how lipid signaling is involved in NSPC
behavior is of crucial importance.
However, given the complex mechanisms of action
and the large variety of signaling lipids, it is beyond
the scope of this review to discuss in detail how lipid
signaling alters NSPC behavior and neurogenesis (for
an in-depth review refer to [15]). That lipid signaling
offers a wide and yet underexplored field for neuro-
genesis is also illustrated by a recent publication: the
receptor 1 for lysophosphatidic acid (LPA), a phos-
pholipid with signaling function that had previously
been shown to be important for brain development
and neurogenesis [98, 99] shows a interesting expres-
sion pattern in the adult DG and has been suggested
as a novel NSPC marker [100]. As this receptor is
a membrane receptor, it provides a novel marker
for fluorescence-activated cell sorting (FACS) based
NSPC isolation. Furthermore, continuous infusion of
LPA over several weeks led to increased survival of
newborn neurons, suggesting that lipids involved in
signaling indeed have the potential to alter neuroge-
nesis [100].
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A LIPID SIGNAL AS A BIOMARKER FOR
HUMAN NSPCS?
Given the many studies discussed above that point
towards an important role of lipids for NSPC behav-
ior using animal models, the question arises whether
this is also true in humans. Interestingly, a specific
signal corresponding to NSPCs has been reported
in live human brains using proton nuclear magnetic
resonance spectroscopy (1H-MRS) [101]. 1H-MRS
allows the identification of metabolites in tissues and
cells in vitro and in vivo, and a comparison of cultured
mouse NSPCs with cultured neurons, astrocytes and
oligodendrocytes showed a characteristic signal peak
that appeared to be unique for NSPCs. This peak
was also significantly higher in cells isolated from
the hippocampus of adult mice compared to cortical
cells and correlated with levels of neurogenesis. The
chemical nature of the peak corresponded to lipids
and the peak decreased with inhibition of fatty acid
synthesis [101]. Further characterization suggested
that it might come from a mix of saturated fatty acids
such as palmitic acid and monounsaturated fatty acids
such as oleic acid. Excitingly, this peak was also iden-
tified and verified with various approaches in adult
rats in vivo and in humans [101], offering potentially
an non-invasive approach to assess neurogenesis in
humans. However, these findings generated concerns,
especially regarding technical aspects and the valid-
ity of the algorithm used to detect this peak, leading
to several comments and responses, all published in
Science [102–104]. Others reported that the signal
was detectable but not specific to NSPCs and rather a
sign for apoptosis [105]. Although this putative lipid
peak is intriguing and fits well with the current knowl-
edge of the important role of lipid metabolism in
NSPCs, further validation and proof of the methods
used are required before this approach might become
clinically relevant.
CONCLUSION
Over the last years, evidence for an important role
of lipid metabolism in the regulation of neurogenesis
has accumulated. Several studies characterized lipid
pathways in NSPCs and their progeny and showed
their importance through manipulation of key com-
ponents of these pathways. However, how exactly
altered lipid metabolism (due to intracellular changes
or due to changes in the extracellular supply) exerts
its function needs to be addressed in more detail.
By combining technological advances, such as for
instance lipidomics (the analysis of the lipid pro-
file by mass spectrometry) and metabolomics (the
analysis of thousands of metabolites by mass spec-
trometry), we will be able to generate a broader and
more unbiased picture of what is happening when
lipid metabolism is changed. Furthermore, isotopic
labeling strategies will allow following the fate of
the lipids in more details. The novel technology of
mass spectrometry-based imaging of metabolites and
lipids in combination with labeling strategies has
opened up an especially powerful method of anal-
ysis [106, 107]. With detailed information about the
spatial location of the studied lipids within a cell or
within a tissue, we might gain new insights about
potential mechanisms of action. As has happened
with conventional imaging, the current resolution and
sensitivity limitations of this technique will likely
be greatly improved in the future. This might even
offer a new way of analysis to address how lipid
signaling (for instance through the addition of a
lipid tag) changes cellular localization of certain
proteins. Last but not least, the promising data on
lipid-based signals via 1H-MRS, which correlate
with in vivo neurogenesis, might open up com-
pletely new avenues to study this important process
in a non-invasive way in humans. It is needless to
say that such a possibility to study neurogenesis
in humans, both in healthy subjects and in patients
with neurological diseases, would revolutionize the
field.
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